Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Cardiometabolic Diseases Market From 2025 To 2029?

The market size for cardiometabolic diseases has seen consistent growth over the recent years. The market’s size is projected to expand from $111.64 billion in 2024 to $115.27 billion in 2025, predicting a compound annual growth rate (CAGR) of 3.3%. This upward trajectory during the historic period is likely due to the rise in sedentary lifestyles, urban and lifestyle changes, industrialisation, consumption of processed foods, genetic factors, and environmental influences.

In the upcoming years, the market size of cardiometabolic diseases is anticipated to record a steady increase, reaching$136.95 billion in 2029 with a compound annual growth rate (CAGR) of 4.4%. Factors contributing to this projected growth in the forecast period include the obesity crisis, continuing aging population, advances in healthcare infrastructure, the rise of genomic and precision medicine, as well as the impact of mental health and chronic stress. Key trends that will mark the forecast period encompass health education and awareness promotion, the implementation of corporate wellness schemes, community health initiatives, a shift towards prevention-focused healthcare, and the adoption of integrated care strategies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11929&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Cardiometabolic Diseases Market?

The cardiometabolic disease market is predicted to grow due to an increasing incidence of obesity. Defined by an abnormal buildup of body fat that results in increased body mass, obesity is directly linked to the emergence of cardiovascular health risks such as dyslipidemia, type 2 diabetes, hypertension, and sleep disorders. In March 2022, the World Health Organization (WHO), a Switzerland-based international organization, reported that more than 1 billion people worldwide are affected by obesity. These numbers include 340 million adolescents, 650 million adults, and 39 million children annually. By 2025, WHO foresees that around 167 million adults and children’s health will deteriorate due to being overweight or obese. Thus, the prevalence of obesity is significantly influencing the expansion of the cardiometabolic diseases market.

Which Key Market Segments Comprise the Cardiometabolic Diseases Market and Drive Its Revenue Growth?

The cardiometabolic diseasesmarket covered in this report is segmented –

1) By Type: Chronic Or Congestive Heart Failure, Hypertension, Type 2 Diabetes, Obesity

2) By Treatment: ACE inhibitors, Diuretics, Glucophage, Liposuction, Other Treatments

3) By Dosage: Tablet, Injection

4) By Route Of Administration: Oral, Intravenous, Other Routes Of Administration

5) By End-Users: Clinic, Hospital, Other End-Users

Subsegments:

1) By Chronic Or Congestive Heart Failure: Systolic Heart Failure; Diastolic Heart Failure

2) By Hypertension: Primary Hypertension; Secondary Hypertension

3) By Type 2 Diabetes: Insulin Resistance; Impaired Glucose Tolerance

4) By Obesity: Class I Obesity (BMI 30-34.9); Class II Obesity (BMI 35-39.9); Class III Obesity (BMI 40 And above)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=11929&type=smp

Which Areas Are Leading Regions in the Cardiometabolic Diseases Market Expansion Across the Globe?

North America was the largest region in the cardiometabolic diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiometabolic diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in theCardiometabolic Diseases Market Over the Coming Years?

The increasing incorporation of cutting-edge technologies is a significant trend being observed in the cardiometabolic diseases market. Firms participating in the cardiometabolic diseases market are striving to harness innovative technologies in order to maintain their market stance. As an example, in February 2023, Eko Health Inc., an American innovator of digital health technologies for detecting heart and lung diseases, unveiled the Sensora cardiac disease identification platform. This platform utilizes artificial intelligence (AI) for the dependable detection of structural murmurs, indicators of valvular heart disease (VHD), and employs care pathway analytics software to offer metrics and deep insight into the patient’s journey through the healthcare system. This digital stethoscope is employed to record and scrutinize electrical impulses and heart rhythms.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cardiometabolic-diseases-global-market-report

How Is the Cardiometabolic Diseases Market Conceptually Defined?

Cardiometabolic diseases refer to a group of interconnected health conditions that impact both the cardiovascular and metabolic systems. These diseases often occur together and share common risk factors, such as obesity, physical inactivity, an unhealthy diet, and genetic predisposition.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11929

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model